ClearPoint Neuro, Inc. (CLPT)
13.96
-0.09
(-0.64%)
USD |
NASDAQ |
Sep 04, 16:00
13.99
+0.03
(+0.21%)
After-Hours: 04:02
ClearPoint Neuro Shareholders Equity (Quarterly) : 10.78M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.78M |
| March 31, 2026 | 18.84M |
| December 31, 2025 | 28.02M |
| September 30, 2025 | 15.87M |
| June 30, 2025 | 19.74M |
| March 31, 2025 | 19.99M |
| December 31, 2024 | 25.39M |
| September 30, 2024 | 29.00M |
| June 30, 2024 | 32.13M |
| March 31, 2024 | 34.58M |
| December 31, 2023 | 21.17M |
| September 30, 2023 | 24.09M |
| June 30, 2023 | 27.41M |
| March 31, 2023 | 32.58M |
| December 31, 2022 | 36.89M |
| September 30, 2022 | 39.88M |
| June 30, 2022 | 42.82M |
| March 31, 2022 | 45.73M |
| December 31, 2021 | 48.79M |
| September 30, 2021 | 44.12M |
| June 30, 2021 | 47.97M |
| March 31, 2021 | 43.98M |
| December 31, 2020 | 2.377M |
| September 30, 2020 | 0.1491M |
| June 30, 2020 | 1.340M |
| Date | Value |
|---|---|
| March 31, 2020 | 2.760M |
| December 31, 2019 | 4.587M |
| September 30, 2019 | 6.008M |
| June 30, 2019 | 6.907M |
| March 31, 2019 | 0.4426M |
| December 31, 2018 | 1.511M |
| September 30, 2018 | 2.493M |
| June 30, 2018 | 3.559M |
| March 31, 2018 | 4.749M |
| December 31, 2017 | 5.829M |
| September 30, 2017 | 7.280M |
| June 30, 2017 | 8.528M |
| March 31, 2017 | -2.205M |
| December 31, 2016 | -0.7561M |
| September 30, 2016 | 0.5746M |
| June 30, 2016 | -3.965M |
| March 31, 2016 | -3.614M |
| December 31, 2015 | -1.981M |
| September 30, 2015 | -5.822M |
| June 30, 2015 | -5.881M |
| March 31, 2015 | -3.630M |
| December 31, 2014 | -0.1003M |
| September 30, 2014 | -7.927M |
| June 30, 2014 | -4.509M |
| March 31, 2014 | -3.138M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| SINTX Technologies, Inc. | 4.83M |
| Penumbra, Inc. | 1.531B |
| Abbott Laboratories | 51.11B |
| AngioDynamics, Inc. | 170.82M |
| Alphatec Holdings, Inc. | 11.53M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 86.74M |
| Total Liabilities (Quarterly) | 75.96M |
| Debt to Equity Ratio | 5.934 |
| Current Ratio | 4.725 |
| Net Debt Paydown Yield | -2.22% |